---
title: "Document: SIMCERE PHARMA issues 121 million shares"
description: "Document: SIMCERE PHARMA issues 121 million shares"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/255465326.md"
published_at: "2025-09-01T11:44:22.000Z"
---

# Document: SIMCERE PHARMA issues 121 million shares

Document: SIMCERE PHARMA issues 121 million shares

### Related Stocks

- [02096.HK - SIMCERE PHARMA](https://longbridge.com/en/quote/02096.HK.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Simcere Signs Exclusive Global Licensing Agreement With Boehringer Ingelheim for SIM0709 | Simcere Pharmaceutical Group Ltd. has signed an exclusive global licensing agreement with Boehringer Ingelheim for SIM07 | [Link](https://longbridge.com/en/news/273811721.md) |
| Sinolink Securities Sticks to Its Buy Rating for Simcere Pharmaceutical Group Limited (2096) | Sinolink Securities analyst maintained a Buy rating on Simcere Pharmaceutical Group Limited on December 27 and set a pri | [Link](https://longbridge.com/en/news/270967374.md) |
| Huatai Securities Sticks to Their Buy Rating for Simcere Pharmaceutical Group Limited (2096) | In a report released yesterday, from Huatai Securities maintained a Buy rating on Simcere Pharmaceutical Group Limited,  | [Link](https://longbridge.com/en/news/270691523.md) |
| Simcere Plans HK Spin-off Listing for Oncology Unit Simcere Zaiming | Simcere Pharmaceutical Group Limited plans to spin off its oncology subsidiary, Simcere Zaiming Pharmaceutical Co., Ltd. | [Link](https://longbridge.com/en/news/272092592.md) |
| Simcere Pharmaceutical Signs Exclusive Licensing Agreement With Ipsen for SIM0613 | Simcere Pharmaceutical's subsidiary, Jiangsu Simcere Zaiming, signed an exclusive licensing agreement with Ipsen Pharma  | [Link](https://longbridge.com/en/news/270440351.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.
